Intercure Ltd.
INCR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001857030
No open-market purchases or sales by Intercure Ltd. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $764.1K in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Intercure Ltd. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 16 | 23 | +7 |
| Shares | 2.36M | 4.15M | +1.79M (+76.1%) |
| Value | $16.3M | $26.9M | +$10.6M (+65.1%) |
New holders (9)
Institutions that held Intercure Ltd. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Mirae Asset Global Investments Co., Ltd. | 836,886 | $5.42M | 0.01% |
| ETF Managers Group, LLC | 552,687 | $3.59M | 0.07% |
| RiverPark Advisors, LLC | 223,930 | $1.45M | 0.17% |
| Vident Investment Advisory, LLC | 58,140 | $375.0K | 0.01% |
| Virtu Financial LLC | 13,052 | $85.0K | 0.01% |
| Penserra Capital Management LLC | 4,547 | $29.0K | 0.00% |
| Acadian Asset Management LLC | 2,837 | $18.0K | 0.00% |
| Banque Cantonale Vaudoise | 2,247 | $15.0K | 0.00% |
| Citigroup Inc | 53 | $0 | 0.00% |
Sold out (2)
Institutions that held Intercure Ltd. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Marshall Wace, LLP | 112,947 | $776.0K |
| Royal Bank of Canada | 101 | $1.00K |